Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and efficacy of ciclopirox olamine cream in children with dermatomycosis
2008-003560-19Phase 4Terminated
- Sponsor
- Novag Infancia
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of ciclopirox in Dermatomycosis of glabrous skin due to yeasts and dermatophytes, sponsored by Novag Infancia. Primary endpoint: Global safety. Started Jul 2008; status: terminated.
02
Drugs
ciclopirox
03
Conditions
Dermatomycosis of glabrous skin due to yeasts and dermatophytes
Beyond the preview
Go deeper on 2008-003560-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003560-19.